Cargando…
Pentosidine in serum and synovial fluid in patients with knee osteoarthritis and its potential role of prediction of osteoarthritis progression
Autores principales: | Pavelka, K, Senolt, L, Vilim, V, Spacek, P, Braun, M, Forejtova, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833958/ http://dx.doi.org/10.1186/ar968 |
Ejemplares similares
-
Serum and bone pentosidine in patients with low impact hip fractures and in patients with advanced osteoarthritis
por: Vaculík, Jan, et al.
Publicado: (2016) -
Pentosidine, an Advanced Glycation End-Product, May Reflect Clinical and Morphological Features of Hand Osteoarthritis
por: Braun, Martin, et al.
Publicado: (2012) -
OPG and RANKL in serum and synovial fluids of patients with rheumatoid arthritis, osteoarthritis and spondylarthropathy
por: Krystufkova, O, et al.
Publicado: (2003) -
Relevance of Biomarkers in Serum vs. Synovial Fluid in Patients with Knee Osteoarthritis
por: Kalogera, Stefania, et al.
Publicado: (2023) -
Serum and synovial fluid cytokine profiling in hip osteoarthritis: distinct from knee osteoarthritis and correlated with pain
por: Ren, Guomin, et al.
Publicado: (2018)